TAHOR for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 11 adverse event reports in the FDA FAERS database where TAHOR was used for Hypercholesterolaemia.
Most Reported Side Effects for TAHOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatocellular injury | 11 | 8.9% | 0 | 8 |
| Rhabdomyolysis | 11 | 8.9% | 2 | 10 |
| Cholestasis | 9 | 7.3% | 0 | 5 |
| Renal failure | 8 | 6.5% | 1 | 7 |
| Thrombocytopenia | 8 | 6.5% | 4 | 6 |
| Drug reaction with eosinophilia and systemic symptoms | 6 | 4.8% | 0 | 6 |
| Inflammation | 6 | 4.8% | 0 | 3 |
| Lung disorder | 6 | 4.8% | 3 | 6 |
| Pancytopenia | 6 | 4.8% | 0 | 6 |
| Weight decreased | 6 | 4.8% | 0 | 1 |
| Abdominal pain upper | 5 | 4.0% | 0 | 4 |
| Diarrhoea | 5 | 4.0% | 0 | 1 |
| Interstitial lung disease | 5 | 4.0% | 2 | 4 |
Other Indications for TAHOR
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
ALIROCUMAB (4,924)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
INCLISIRAN (486)
FENOFIBRATE (286)
FLUVASTATIN (264)